Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients

Conclusion: The infiltration of activated fibroblasts, especially the FSP-1+ or podoplanin+ fibroblasts leads to worse clinical outcome in breast cancer patients, implicating that it is a valuable prognostic biomarker and targeting it may have a potential for effective treatment.

http://www.jcancer.org/v09p3736.htm

Source: Journal of Cancer - December 14, 2018 Category: Cancer & Oncology Authors: Guoming Hu, Feng Xu, Kefang Zhong, Shimin Wang, Liming Huang, Wei Chen Tags: Research Paper Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | Study